UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 774

Sortiert nach

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1825-1835

2013

Volltextzugriff (PDF)

Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy

Journal of cancer research and clinical oncology, 2008-10, Vol.134 (10), p.1079-1086

2008

Volltextzugriff (PDF)

Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself

Breast cancer research and treatment, 2005-11, Vol.94 (1), p.17-23

2005

Volltextzugriff (PDF)

Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer

Journal of cancer research and clinical oncology, 2008-08, Vol.134 (8), p.873-882

2008

Volltextzugriff (PDF)

Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany

Breast (Edinburgh), 2018-02, Vol.37, p.89-98

2018

Volltextzugriff (PDF)

A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii72-viii72

2018

Volltextzugriff (PDF)

Risk and risk assessment for breast cancer: Molecular and clinical aspects

Maturitas, 2007-05, Vol.57 (1), p.56-60

2007

Volltextzugriff (PDF)

Factors correlating with reexcision after breast-conserving therapy

European journal of surgical oncology, 2009-01, Vol.35 (1), p.32-37

2009

Volltextzugriff (PDF)

Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany

Cancer treatment and research communications, 2022, Vol.31, p.100519-100519, Article 100519

2022

Volltextzugriff (PDF)

Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network

Geburtshilfe und Frauenheilkunde, 2015-01, Vol.75 (1), p.41-50

2015

Volltextzugriff (PDF)

Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study

Geburtshilfe und Frauenheilkunde, 2017-06, Vol.77 (6), p.651-659

2017

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy in Breast Cancer: Which Diagnostic Procedures Can be Used?

Anticancer research, 2005-05, Vol.25 (3C), p.2519-2525

2005

Volltextzugriff (PDF)

Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy

Geburtshilfe und Frauenheilkunde, 2017-02, Vol.77 (2), p.169-175

2017

Volltextzugriff (PDF)

Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients

European journal of surgical oncology, 2012-01, Vol.38 (1), p.44-51

2012

Volltextzugriff (PDF)

Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies

Supportive care in cancer, 2007-11, Vol.15 (11), p.1277-1284

2007

Volltextzugriff (PDF)

Ökonomische Rahmenbedingungen der Frauenheilkunde

Gynäkologe (Berlin), 2011-10, Vol.44 (10), p.786-787

2011

Volltextzugriff (PDF)

Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies

European journal of surgical oncology, 2007-02, Vol.33 (1), p.39-43

2007

Volltextzugriff (PDF)

Breast Cancer Risk – From Genetics to Molecular Understanding of Pathogenesis

Geburtshilfe und Frauenheilkunde, 2013-12, Vol.73 (12), p.1228-1235

2013

Volltextzugriff (PDF)

Establishment of the Certification System “Gynaecological Dysplasia” in Germany

Geburtshilfe und Frauenheilkunde, 2014-09, Vol.74 (9), p.860-867

2014

Volltextzugriff (PDF)

Changes in satisfaction in patients with gynaecological and breast malignancies: an analysis with the Socio-Economic Satisfaction and Quality of Life questionnaire

European journal of cancer care, 2007-11, Vol.16 (6), p.508-516

2007

Volltextzugriff (PDF)

Breast Cancer Risk – Genes, Environment and Clinics

Geburtshilfe und Frauenheilkunde, 2011-12, Vol.71 (12), p.1056-1066

2011

Volltextzugriff (PDF)

Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation

Gesundheitswesen (Bundesverband der Ärzte des Öffentlichen Gesundheitsdienstes (Germany)), 2016-07, Vol.78 (7), p.438

2016

Volltextzugriff (PDF)

Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-up

Geburtshilfe und Frauenheilkunde, 2016-01, Vol.76 (1), p.59-64

2016

Volltextzugriff (PDF)

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer

European journal of cancer prevention, 2000-06, Vol.9 (3), p.139-150

2000

Volltextzugriff (PDF)

Breast Cancer Update 2014 – Focus on the Patient and the Tumour

Geburtshilfe und Frauenheilkunde, 2015-02, Vol.75 (2), p.170-182

2015

Volltextzugriff (PDF)

1 – 25 von 774

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(697)
Mit Volltextzugriff
(711)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(421)
Life Sciences & Biomedicine
(261)
Humans
(177)
Female
(131)
Physical Sciences
(112)
Biological And Medical Sciences
(107)
Physics
(102)
Technology
(89)
Middle Aged
(84)
Adult
(80)
Male
(72)
Medical Sciences
(69)
Breast Cancer
(68)
Oncology
(66)
Animals
(60)
Aged
(56)
Materials Science
(49)
Obstetrics & Gynecology
(47)
Physics, Applied
(45)
Fundamental And Applied Biological Sciences. Psychology
(43)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy

Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself

Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer

Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany

A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients

Risk and risk assessment for breast cancer: Molecular and clinical aspects

Factors correlating with reexcision after breast-conserving therapy

Budget impact of the Oncotype DX® test compared to other gene expression tests in patients with early breast cancer in Germany

Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network

Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study

Neoadjuvant Chemotherapy in Breast Cancer: Which Diagnostic Procedures Can be Used?

Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy

Accuracy of radiological tumour size assessment and the risk for re-excision in a cohort of primary breast cancer patients

Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies

Ökonomische Rahmenbedingungen der Frauenheilkunde

Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies

Breast Cancer Risk – From Genetics to Molecular Understanding of Pathogenesis

Establishment of the Certification System “Gynaecological Dysplasia” in Germany

Changes in satisfaction in patients with gynaecological and breast malignancies: an analysis with the Socio-Economic Satisfaction and Quality of Life questionnaire

Breast Cancer Risk – Genes, Environment and Clinics

Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation

Touch Imprint Cytology and Stereotactically-Guided Core Needle Biopsy of Suspicious Breast Lesions: 15-Year Follow-up

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer

Breast Cancer Update 2014 – Focus on the Patient and the Tumour

Suchergebnisse filtern